NCT06736678View on ClinicalTrials.gov

Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
Pancreatic CancerNeoadjuvant ChemoradiotherapyImmunonutrition
Interventions
DIETARY_SUPPLEMENT

Oral Immunonutrition

Patients receive enteral immunonutrition, Oral Impact® Nestle for 6 weeks from one week before radiotherapy;

Trial Locations (2)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

Unknown

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER